e-learning
resources
Virtual 2020
Tuesday, 08.09.2020
French programme 2020: Part I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Tt anti fibrotiques hors FPI: approche raisonnée / Anti-fibrotic treatments for conditions other than idiopathic pulmonary fibrosis
V. Cottin (Lyon, France)
Source:
Virtual Congress 2020 – French programme 2020: Part I
Session:
French programme 2020: Part I
Session type:
Language session
Number:
4557
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Cottin (Lyon, France). Tt anti fibrotiques hors FPI: approche raisonnée / Anti-fibrotic treatments for conditions other than idiopathic pulmonary fibrosis. Virtual Congress 2020 – French programme 2020: Part I
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Mucoviscidose: enfin des traitements ciblés / Cystic fibrosis: targeted therapies, at last !
Source: Virtual Congress 2020 – French programme 2020: Part I
Year: 2020
Place des anti-IL5 dans les pathologies éosinophiliques (hors asthme sévère) / Anti-IL-5 therapy for indications other than severe asthma
Source: Virtual Congress 2020 – French programme 2020: Part II
Year: 2020
Does emphysema influence the application of du Bois score in idiopathic pulmonary fibrosis?
Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Year: 2012
Exacerbation aiguë de la fibrose pulmonaire idiopathique: ce qu'il ne faut plus faire et ce qu'il reste à faire. / Acute exacerbation of idiopathic pulmonary fibrosis: what should not be done and what remains to be done?
Source: Virtual Congress 2021 – French programme 2021
Year: 2021
Syndrome obésité-hypoventilation: de la physiologie au traitementObesity hypoventilation: from pathophysiology to treatment
Source: International Congress 2016 – ERS/French Programme I
Year: 2016
Prise en charge de l’aspergillose pulmonaire chronique Chronic pulmonary aspergillosis care
Source: International Congress 2017 – French Programme 2017
Year: 2017
Prise en charge de l’emphysème : Approche personnalisée / Management of emphysema: personalised approach
Source: Virtual Congress 2021 – French programme 2021
Year: 2021
Nuevos tratamientos para la fibrosis pulmonar
Source: Annual Congress 2013 –Sesión conjunta en castellano organizada por la SEPAR (España) y la ALAT (Latinamérica)
Year: 2013
Régulation de l'inflammation dans l'asthme : IL37 vs IL17Inflammatory regulation in asthma: IL37 vs IL17
Source: International Congress 2017 – French Programme 2017
Year: 2017
Thermoplastie bronchique : indications actuelles / Asthma thermoplasty: current indications
Source: Virtual Congress 2021 – French programme 2021
Year: 2021
Cirrhose cardiaque in pulmonary hypertension- a case series.
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018
Diagnostic de l’EP chez la femme enceinte / Diagnosis of pulmonary embolism in pregnant women
Source: Virtual Congress 2020 – French programme 2020: Part II
Year: 2020
Risques cardiovasculaires et BPCO / Cardiovascular risks and COPD
Source: Virtual Congress 2020 – French programme 2020: Part II
Year: 2020
Réduction volumique par spirales dans le traitement de l’emphysème sévèreLung reduction coil treatment in severe emphysema
Source: International Congress 2016 – ERS/French Programme I
Year: 2016
La thermoplastie dans l’asthme : corrélation clinique et histopathologiqueAsthma thermoplasty: clinical and histopathological correlation
Source: International Congress 2017 – French Programme 2017
Year: 2017
Pneumopathies infiltrantes diffuses sous immunothérapie / Interstitial lung diseases and immunotherapy
Source: Virtual Congress 2021 – French programme 2021
Year: 2021
Exploration de la fonction respiratoire selon l'âge / Lung function testing and age
Source: Virtual Congress 2020 – French programme 2020: Part II
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept